FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Goldman Sachs analyst Madhu Kumar lowered the price target on Editas Medicine (NASDAQ: EDIT) to $10.00 (from $18.00) while maintaining a Sell rating.
... More

